Carol Aghajanian

12PUBLICATIONS
184CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 14, 2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Nov 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.

Angela K Green, Qin Zhou, Alexia Iasonos

|Jun 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.

Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang

|Aug 29, 2023
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.

Claire F Friedman, Vignesh Ravichandran, Kathryn Miller

Pageof 2